New study reveals molecular mechanism in Alzheimer’s disease

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer’s patients.

Xlife Sciences AG enables international co-investors to enter the stock and is planning a dual listing on the London Stock Exchange Group (LSEG) – Biotech Investments

Xlife Sciences AG / Key word(s): Alliance/Strategic Company Decision 30-Sep-2024 / 20:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

October 1, 2024

Pharmalittle: We’re reading about Lilly buying a plant, a Pfizer antibiotic, and more

Top of the morning to you, and a fine one it is. There is nothing like being greeted with clear blue skies and cool breezes

April 23, 2024

A Big Round Trip

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.